Dominique Costagliola Selected Research

Natural Cytotoxicity Triggering Receptor 2

1/2009	[Towards a vaccine for HIV infection: role of the gp41 envelope protein].
9/2006	Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominique Costagliola Research Topics

Disease

54	Acquired Immunodeficiency Syndrome (AIDS) 07/2022 - 05/2002
40	Infections 07/2022 - 05/2002
32	HIV Infections (HIV Infection) 11/2021 - 05/2003
20	Neoplasms (Cancer) 01/2022 - 09/2003
9	Disease Progression 11/2015 - 12/2002
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 09/2006
8	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2020 - 07/2006
6	Lymphoma (Lymphomas) 12/2021 - 02/2009
6	Myocardial Infarction 01/2020 - 11/2003
5	COVID-19 03/2022 - 12/2021
5	Hodgkin Disease (Hodgkin's Disease) 12/2021 - 10/2009
5	Viremia 01/2020 - 11/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2009
5	Opportunistic Infections (Opportunistic Infection) 01/2014 - 12/2002
4	Inflammation (Inflammations) 04/2016 - 01/2007
4	Hepatitis B 10/2014 - 01/2002
3	Lipodystrophy 04/2022 - 01/2008
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2022 - 10/2014
3	Hypertension (High Blood Pressure) 01/2019 - 08/2014
3	Progressive Multifocal Leukoencephalopathy 01/2018 - 01/2011
3	Anus Neoplasms (Anal Cancer) 12/2017 - 06/2008
3	Coinfection 01/2015 - 06/2014
3	Sexually Transmitted Diseases (Sexually Transmitted Disease) 06/2014 - 06/2004
2	Hepatitis 07/2022 - 02/2005
2	Pneumonia (Pneumonitis) 01/2022 - 02/2013
2	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2020
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2020 - 01/2018
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 11/2017
2	AIDS Dementia Complex 01/2018 - 07/2014
2	Hepatitis C 06/2014 - 06/2005
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2013 - 01/2006
2	Metabolic Bone Diseases (Osteopenia) 09/2013 - 10/2012
2	Squamous Intraepithelial Lesions 01/2013 - 01/2006
2	Osteoporosis 10/2012 - 09/2012
2	Tuberculosis (Tuberculoses) 05/2012 - 03/2010
2	ST Elevation Myocardial Infarction 01/2012 - 02/2011
2	Hemorrhage 01/2012 - 02/2011
2	Human Influenza (Influenza) 05/2010 - 02/2008
1	Chronic Renal Insufficiency 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Hepatorenal Syndrome 01/2022
1	Obesity 12/2021
1	Heart Diseases (Heart Disease) 12/2021
1	Reinfection 06/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2020

Drug/Important Bio-Agent (IBA)

17	RNA (Ribonucleic Acid)IBA 01/2019 - 05/2003
13	Pharmaceutical PreparationsIBA 06/2014 - 07/2002
11	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 05/2002
10	Reverse Transcriptase InhibitorsIBA 01/2022 - 05/2003
9	NucleosidesIBA 01/2022 - 05/2003
8	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2009
7	VaccinesIBA 02/2011 - 12/2002
6	Ritonavir (Norvir)FDA Link 12/2021 - 05/2003
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2003
5	EnzymesIBA 04/2022 - 10/2008
5	AntibodiesIBA 03/2022 - 02/2002
4	Antiviral Agents (Antivirals)IBA 01/2022 - 10/2007
4	Lopinavir FDA Link 12/2021 - 01/2005
4	Proteins (Proteins, Gene)FDA Link 06/2021 - 12/2002
4	Raltegravir Potassium FDA Link 10/2020 - 06/2014
4	Atazanavir Sulfate (Reyataz)FDA Link 01/2020 - 04/2015
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017 - 05/2011
4	Interleukin-2 (IL2)IBA 10/2010 - 01/2002
4	abacavir (Ziagen)FDA Link 08/2010 - 01/2005
3	Tenofovir (Viread)FDA Link 07/2022 - 01/2005
3	etravirine (TMC-125)FDA Link 10/2020 - 01/2014
3	Maraviroc FDA Link 01/2020 - 06/2014
3	efavirenz (Sustiva)FDA Link 01/2018 - 08/2012
3	Anti-Retroviral Agents (Antiretroviral Agents)IBA 02/2013 - 01/2006
2	Immunoglobulin G (IgG)IBA 02/2022 - 02/2002
2	Oxygen (Dioxygen)IBA 01/2022 - 12/2021
2	remdesivirIBA 01/2022 - 01/2022
2	CytokinesIBA 12/2021 - 05/2010
2	A-factor (Streptomyces)IBA 11/2021 - 06/2007
2	Neutralizing AntibodiesIBA 06/2021 - 05/2010
2	InterferonsIBA 06/2021 - 01/2011
2	Darunavir (Prezista)FDA Link 01/2020 - 01/2018
2	Growth Hormone (Somatotropin)IBA 01/2020 - 01/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2017 - 09/2006
2	Rituximab (Mabthera)FDA Link 11/2017 - 09/2006
2	LipidsIBA 01/2017 - 01/2010
2	Rosuvastatin Calcium (Crestor)FDA Link 04/2016 - 01/2010
2	Natural Cytotoxicity Triggering Receptor 2IBA 01/2009 - 09/2006
2	LigandsIBA 01/2009 - 09/2006
2	Zidovudine (Retrovir)FDA LinkGeneric 01/2007 - 04/2004
1	Emtricitabine (Emtriva)FDA Link 07/2022
1	Immunoglobulin M (IgM)IBA 02/2022
1	Ribavirin (Virazole)FDA LinkGeneric 01/2022
1	IntegrasesIBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021
1	Viral ProteinsIBA 06/2021

Therapy/Procedure

62	Therapeutics 01/2022 - 05/2002
45	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 07/2002
6	Art Therapy 01/2020 - 06/2013
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2006
2	Percutaneous Coronary Intervention 01/2012 - 02/2011
1	Mechanical Ventilators (Ventilator) 01/2022
1	Contraindications 01/2022
1	Immunotherapy 01/2022
1	Condoms (Condom) 11/2021